33.950
+0,15%
2026-07-01
Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +111.6% | +1487.6% | 3 / 3 | -24.9% | -10.83 pp | +32.96 pp | +28.6% | 0.60 | 9.54 | 25,0 | −24,9% | 1,2 | +113,1% | 9.54 | 11.19 | −14,7% |
| Pts | 12 | 12 | 12 | 0 | 0 | 12 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 33.950 (close price on 2026-07-01)EPS (TTM): 3.558
Financial charts
1.Revenue & growth
VND bn25,0Q2/26
1.Revenue & growth
VND bn25,0Q2/26
2.Profit & growth
VND bn1,09Q2/26
3.Profit mix (Penman)
VND bn99,4Q2/26
4.Margins & cost structure
%58.4%Q2/26
5.Returns & cash cycle
% · days9.5%Q2/26
6.Earnings quality & cash
VND bn187Q2/26
7.Asset structure
VND bn751Q2/26
8.Funding & debt health
VND bn · times751Q2/26
9.Revenue backlog
VND bn0,62Q2/26
10.Valuation
times · %9,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %38Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
22,8× higher
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26